(Q38781442)

6 September 2017

h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases (English)

1 reference

6 September 2017

6

Hideki Ohdan

1 reference

6 September 2017

3

Hirotaka Tashiro

1 reference

6 September 2017

2

Tsuyoshi Kobayashi

1 reference

6 September 2017

4

Koji Arihiro

1 reference

6 September 2017

1

Masakazu Hashimoto

1 reference

6 September 2017

Akira Kikuchi

5

1 reference

PubMed ID

27037526

6 September 2017

language of work or name

English

0 references

publication date

31 March 2016

1 reference

International Journal of Cancer

6 September 2017

1 reference

6 September 2017

139

1 reference

6 September 2017

4

1 reference

6 September 2017

812-823

1 reference

Liver metastases from colorectal cancer: lessons from past and present clinical studies

6 September 2017

1 reference

Surgical management and outcomes of colorectal cancer liver metastases

21 January 2018

1 reference

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

21 January 2018

1 reference

Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis.

21 January 2018

1 reference

Human metastasis regulator protein H-prune is a short-chain exopolyphosphatase

21 January 2018

1 reference

Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions

21 January 2018

1 reference

h-Prune is an independent prognostic marker for survival in esophageal squamous cell carcinoma

21 January 2018

1 reference

Epithelial-mesenchymal transitions in development and pathologies

21 January 2018

1 reference

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

21 January 2018

1 reference

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase

21 January 2018

1 reference

Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver.

21 January 2018

1 reference

Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases

21 January 2018

1 reference

Hepatic resection for colorectal metastasis: impact of tumour size

21 January 2018

1 reference

KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases

21 January 2018

1 reference

Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases

21 January 2018

1 reference

BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.

21 January 2018

1 reference

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.

21 January 2018

1 reference

H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC

21 January 2018

1 reference

Nm23/nucleoside diphosphate kinase in human cancers

21 January 2018

1 reference

Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential

21 January 2018

1 reference

Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma

21 January 2018

1 reference

nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition

21 January 2018

1 reference

ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients.

21 January 2018

1 reference

Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapy

21 January 2018

1 reference

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

21 January 2018

1 reference

Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers

21 January 2018

1 reference

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

21 January 2018

1 reference

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma

21 January 2018

1 reference

Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

21 January 2018

1 reference

Novel pyrimidopyrimidine derivatives for inhibition of cellular proliferation and motility induced by h-prune in breast cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30118

1 reference

6 September 2017

1 reference

PubMed ID

27037526